Xepi

Chemical Nameozenoxacin
Dosage FormCream (topical; 1%)
Drug ClassAntimicrobials
SystemSkin
CompanyCutanea Life Sciences, Inc.
Approval Year2017

Indication

  • Topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older.
Last updated on 10/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xepi (ozenoxacin) Prescribing Information 2018Cutanea Life Sciences, Inc., Wayne, PA.